What does Allogene Therapeutics, Inc. (ALLO) do?

Allogene Therapeutics, Inc. (ALLO) is a publicly traded company.

What sector does ALLO operate in?

Allogene Therapeutics, Inc. operates in the equity market. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find research and analysis for ALLO?

AlphaOS provides AI-assisted research, earnings transcripts, SEC filing analysis, opportunity scoring, and knowledge-graph relationships for Allogene Therapeutics, Inc. (ALLO). All content is for research and education — not investment advice.

Allogene Therapeutics, Inc. (ALLO)

US equity research on AlphaOS

Allogene Therapeutics, Inc. operates in unknown sector.

Allogene Therapeutics, Inc. key market context on AlphaOS includes Market capitalization: $686.86M; Recent price: $1.99. Figures update as market data and SEC filings are ingested.

Use this ALLO research hub for earnings transcripts, SEC filings, opportunity scoring, news, and knowledge-graph relationships. Content is for research and education only — not investment advice.

Key facts

Market cap:: $686.86M
Revenue:: $0

Interactive charts, filings, and live quotes load below. Research & analysis only — not investment advice.

Intelligence coverage: 55%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

ALLO

Allogene Therapeutics, Inc.

$1.99Jun 18, 2026

AI confidence 50% · prior close shown (market closed)

Loading earnings intelligence…

Opening stock page...

Fetching company snapshot, pricing, and intelligence.